Novarex Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 431

Employees

  • Stock Symbol
  • 194700

Stock Symbol

  • Share Price
  • $7.33
  • (As of Thursday Closing)

Novarex General Information

Description

Novarex Co Ltd offers dietary supplements including Lactomin, Probiotics, Microencapsulation, Health Supplement, Dietary Supplement, Nutrition, Omega-3, Vitamin, among others.

Contact Information

Website
www.novarex.co.kr
Formerly Known As
Health Science Corporation
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 80, Osongsaengmyeong 14-ro
  • Osong-eup, Heungdeok-gu
  • Cheongiu-si, Chungcheongbuk-do
  • South Korea
+82 000-000-0000
Primary Industry
Food Products
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
LOHAS & Wellness
Corporate Office
  • 80, Osongsaengmyeong 14-ro
  • Osong-eup, Heungdeok-gu
  • Cheongiu-si, Chungcheongbuk-do
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novarex Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.33 $7.23 $6.46 - $10.28 $130M 17.7M 249K $0.94

Novarex Financials Summary

In Thousands,
USD 		TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 128,453 175,284 147,312 287,079
Revenue 221,130 231,112 217,995 243,395
EBITDA 26,475 27,159 25,520 32,447
Net Income 16,622 16,854 15,467 23,050
Total Assets 202,079 205,430 214,252 213,974
Total Debt 16,521 18,357 36,599 46,066
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novarex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novarex‘s full profile, request access.

Request a free trial

Novarex Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Novarex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11096979-B2 Pharmaceutical composition for preventing or treating liver diseases, containing licorice extract containing glycyrrhizin and liquiritin Active 25-Apr-2016 0000000000 0
US-20190134130-A1 Pharmaceutical composition for preventing or treating liver diseases, containing licorice extract containing glycyrrhizin and liquiritin Active 25-Apr-2016 0000000000

Novarex Executive Team (3)

Name Title Board Seat
Seok-hyung Kwon Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Novarex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novarex FAQs

  • When was Novarex founded?

    Novarex was founded in 1995.

  • Who is the CEO of Novarex?

    Seok-hyung Kwon is the CEO of Novarex.

  • Where is Novarex headquartered?

    Novarex is headquartered in Cheongiu-si, South Korea.

  • What is the size of Novarex?

    Novarex has 431 total employees.

  • What industry is Novarex in?

    Novarex’s primary industry is Food Products.

  • Is Novarex a private or public company?

    Novarex is a Public company.

  • What is Novarex’s stock symbol?

    The ticker symbol for Novarex is 194700.

  • What is the current stock price of Novarex?

    As of 12-Sep-2024 the stock price of Novarex is $7.33.

  • What is the current market cap of Novarex?

    The current market capitalization of Novarex is $130M.

  • What is Novarex’s current revenue?

    The trailing twelve month revenue for Novarex is $221M.

  • What is Novarex’s annual earnings per share (EPS)?

    Novarex’s EPS for 12 months was $0.94.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »